Cytosorbents Corp (CTSO): Shares Outstanding

Annual figures by period end, from SEC filings.

62.80M
As of 2025-12-31
62.84M
As of 2026-06-30
+12.9%
3-year compound annual growth
+7.8%
5-year compound annual growth
+9.5%
10-year compound annual growth
214.97M2010-12-31: 122.84M2011-12-31: 177.63M2012-12-31: 214.97M2013-12-31: 10.05M2014-12-31: 23.30M2015-12-31: 25.40M2016-12-31: 25.48M2017-12-31: 28.97M2018-12-31: 31.77M2019-12-31: 32.62M2020-12-31: 43.22M2021-12-31: 43.64M2022-12-31: 43.64M2023-12-31: 54.24M2024-12-31: 54.83M2025-12-31: 62.80M62.80M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3162.80M+14.5%2026-03-30, Balance as of period end
2024-12-3154.83M+1.1%2026-03-30, Balance as of period end
2023-12-3154.24M+24.3%2025-03-31, Balance as of period end
2022-12-3143.64M0.0%2024-03-15, Balance as of period end
2021-12-3143.64M+1.0%2023-03-09, Balance as of period end
2020-12-3143.22M+32.5%2022-03-10, Balance as of period end
2019-12-3132.62M+2.6%2021-03-09, Balance as of period end
2018-12-3131.77M+9.7%2020-03-05, Balance as of period end
2017-12-3128.97M+13.7%2019-03-07, Balance as of period end
2016-12-3125.48M+0.3%2018-03-08, Balance as of period end
2015-12-3125.40M+9.0%2017-03-03, Balance as of period end
2014-12-3123.30M+131.8%2016-03-09, Balance as of period end
2013-12-3110.05M-95.3%2015-03-31, Balance as of period end
2012-12-31214.97M+21.0%2014-03-31, Balance as of period end
2011-12-31177.63Mn/c2013-04-03, Balance as of period end
2010-12-31122.84Mn/a2012-03-30, Balance as of period end